September 2026
Added to Dediabetes Sep 3, 2026RCTs
This study evaluated the efficacy and safety of nanocurcumin supplementation in patients with diabetic peripheral neuropathy, finding no significant differences between the treatment and placebo groups.
Interventions
Nanocurcumin
Outcomes
ASTAlanine transaminase levels at 12 monthsC-reactive protein+11 more
Added to Dediabetes Sep 3, 2026RCTs
This study evaluated the effects of dapagliflozin on diastolic function and exercise capacity in patients with type 2 diabetes and stage B heart failure, finding significant improvements in certain cardiac measures and exercise capacity.
Interventions
Dapagliflozin 10 mg/day
Outcomes
6-minute walk distanceAverage E/e'Decrease in Abdominal Volume Index+2 more
Added to Dediabetes Sep 1, 2026RCTs
This study investigated the effects of whey protein supplementation on glycemia in type 2 diabetes patients, finding significant improvements in insulin and GLP-1 secretion.
Interventions
Whey protein
Outcomes
BMIGLP-1GLP-1 secretion stimulated by whey protein+5 more
Added to Dediabetes Sep 1, 2026RCTs
This study investigated the effects of different doses of whey protein isolate on metabolic markers in overweight women with prediabetes. No significant differences were found across the interventions.
Interventions
whey protein 20g
Outcomes
Fasting Plasma Glucose (FPG)Insulin resistancePlasma lipid profile
Added to Dediabetes Sep 1, 2026RCTs
This study investigated the impact of prebiotic fibers on appetite regulation in individuals with type 2 diabetes, revealing no significant differences in appetite-related hormones or ratings between the interventions.
Interventions
Inulin-type fructans
Outcomes
Fullness ratings assessed using a visual analogue scaleGhrelinHunger scores+3 more
Added to Dediabetes Sep 1, 2026RCTs
This study investigated the effects of dietary fiber supplementation on gestational diabetes risk and pregnancy outcomes, finding significant improvements in glucose levels and weight gain.
Interventions
Normal careSoluble dietary fiber supplementation
Outcomes
C-peptide incremental area under the curve (iAUC)Gestational diabetes mellitus incidenceGestational weight gain+3 more
August 2026
Added to Dediabetes Aug 29, 2026RCTs
This study evaluated the feasibility and acceptability of the MyHealthAvatar-Diabetes smartphone app for reducing prolonged sitting in individuals with Type 2 Diabetes Mellitus, showing promising preliminary outcomes.
Interventions
MyHealthAvatar-Diabetes smartphone app
Outcomes
2-hour plasma glucoseAverage number of breaks in sitting per dayBody fat percentage reduction+8 more
Added to Dediabetes Aug 29, 2026RCTs
This study examined the impact of insulin pump treatment and continuous glucose monitoring on sleep and hypoglycemia fear in children with Type 1 Diabetes, finding no significant differences in outcomes.
Interventions
Insulin pumpSAP with SmartGuard feature (Minimed 640G)
Outcomes
Daytime Sleepiness in ChildrenDaytime Sleepiness in ParentsFear of hypoglycemia (worry)+2 more
Added to Dediabetes Aug 29, 2026RCTs
Long-term treatment with lemborexant improved sleep onset and maintenance in diabetic patients with insomnia.
Interventions
Lemborexant 10mgLemborexant 5mg
Outcomes
Sleep efficiencySleep onset delay scoreTotal sleep time measured in minutes+2 more
Added to Dediabetes Aug 28, 2026RCTs
This study evaluated the impact of a social media-based diabetes education program on patients with Type 2 diabetes. It found significant improvements in diabetes knowledge, attitudes, and self-care activities.
Interventions
Remote multiprofessional educational program
Outcomes
Diabetes Care Profile–Attitudes Toward Diabetes Scales (DCP-ATDS)Diabetes knowledgeDiabetes self-management behaviors+2 more